Skip to main content
. Author manuscript; available in PMC: 2008 Nov 10.
Published in final edited form as: Virology. 2007 Jul 23;368(1):145–154. doi: 10.1016/j.virol.2007.06.029

Fig. 5. CV-N resistant viruses demonstrate increased sensitivity to V3 loop-directed MAbs.

Fig. 5

Anti-HIV-1 activity was assessed in TZM-bl cells by infecting with HIV-1IIIB, CV or GCV in the presence of serially diluted (A) MAb 2G12, (B) MAb 447-52D and (C) MAb 1101. The infectivity of each virus in medium alone culture was arbitrarily set to 100%. Data are representative of 3 independent experiments, with each determination performed in triplicate (mean ± SD). * P<0.01, compared with HIV-1IIIB.